Postoperative Hypofractionated Intensity-modulated Radiotherapy Endometrial Cancer

To investigate the non-inferiority of disease-free survival in women who received hypofractionated intensity-modulated whole pelvic radiation therapy (2.5 Gy x 16 fractions) after curative surgery for stage III endometrial cancer.

Trial Details

NCT ID
NCT05876130
Phase
NA
Sponsor
Samsung Medical Center
Status
RECRUITING
Cancer Type
Uterine Cancer
Interventions
  • POHIM_EM
Locations (sample)
  • Seoul, South Korea|37.566,126.9784

Key Eligibility Criteria

  • histologically confirmed endometrioid type endometrial cancer
  • completion of hysterectomy and surgical staging
  • pathologically confirmed FIGO stage III
  • ECOG performance status 0 or 1

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Uterine Cancer Trials on Trialify →